| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 102,049 | 90,987 | 88,211 | 92,228 | | Cost of Revenue | 24,392 | 23,855 | 22,914 | 23,310 | | | Gross Profit | 77,657 | 67,132 | 65,297 | 68,918 | | | Operating Expenses | | Research Development | 17,302 | 17,028 | 16,038 | 15,380 | | Selling General and Administrative | 53,489 | 51,117 | 49,779 | 59,405 | | Non Recurring | (3,008) | (2,959) | 1,520 | (11,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,874 | 1,946 | (2,040) | 5,133 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 141 | 45 | 638 | 1,455 | | Earnings Before Interest And Taxes | 10,015 | 1,991 | (1,402) | 6,588 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 10,015 | 1,991 | (1,402) | 6,588 | | Income Tax Expense | 4,546 | 2,281 | (2,376) | (16,667) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,469 | (290) | 974 | 23,255 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,469 | (290) | 974 | 23,255 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,469 | ($290) | $974 | $23,255 |
|
0.09% Nasdaq 
Income Statement
